IL1B and type 1 diabetes mellitus: These data are in accordance with previous studies suggesting that beta cells differentiated from iPSCs derived from healthy donors or T1D patients are sensitive to a cocktail of pro-inflammation cytokines, i.e., TNFα + IL-1β + IFNγ [13, 14].